Mark C. Schneyer
2021
Compensation breakdown
| Non-Equity Incentive Plan | $52,337 |
|---|---|
| Option Awards | $544,236 |
| Salary | $398,183 |
| Stock Awards | $2,083,089 |
| Other | $104,973 |
| Total | $3,182,819 |
Schneyer received $2.1M in stock awards, accounting for 65% of the total pay in 2021.
Schneyer also received $52.3K in non-equity incentive plan, $544.2K in option awards, $398.2K in salary and $105K in other compensation.
Rankings
In 2021, Mark C. Schneyer's compensation ranked 4,205th out of 12,415 executives tracked by ExecPay. In other words, Schneyer earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,205 out of 12,415 | 66th |
Division Manufacturing | 1,731 out of 5,505 | 69th |
Major group Chemicals And Allied Products | 721 out of 2,375 | 70th |
Industry group Drugs | 643 out of 2,096 | 69th |
Industry Pharmaceutical Preparations | 453 out of 1,546 | 71st |
Pay ratio
| Mark C. Schneyer's Pay | $3,182,819 |
|---|---|
| Median Employee's Pay | $219,387 |
| Pay Ratio | 15to 1 |
In 2021, the annual total compensation of Mark C. Schneyer was $3,182,819.
The annual total compensation of the median employee at ACADIA Pharmaceuticals was $219,387.
The ratio of Mark C. Schneyer's pay to the pay of median employee was therefore 15 to one.
Schneyer's colleagues
We found five more compensation records of executives who worked with Mark C. Schneyer at ACADIA Pharmaceuticals in 2021.
2021
Stephen Davis
ACADIA Pharmaceuticals
Chief Executive Officer
2021
Srdjan Stankovic
ACADIA Pharmaceuticals
President
2021
Brendan Teehan
ACADIA Pharmaceuticals
Chief Operating Officer
2021
Elena Ridloff
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Austin Kim
ACADIA Pharmaceuticals